| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/05/2002 | US6344542 A polypeptides involved in signal transduction; therapy and diagnosis of cancers, diabetes, obesity, anorexia, asthma, parkinson's disease, heart disease, strokes, allergies, schizophrenia, huntington's disease and tourett's syndrome |
| 02/05/2002 | US6344541 DKR polypeptides |
| 02/05/2002 | US6344450 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | US6344446 Gene delivery |
| 02/05/2002 | US6344445 Herpes virus vectors and their uses |
| 02/05/2002 | US6344443 Peptide antagonists of tumor necrosis factor alpha |
| 02/05/2002 | US6344442 Biodegradable inserts |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344440 Antisecretory factor peptides regulating pathological permeability changes |
| 02/05/2002 | US6344439 Agents for promoting bone formation |
| 02/05/2002 | US6344438 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating the eyes or eyelids |
| 02/05/2002 | US6344437 Medicine drink food and feed having an action of strengthening bone |
| 02/05/2002 | US6344436 Gene delivery to cells |
| 02/05/2002 | US6344342 An isolated polynucleotide encoding a polypeptide; diagnosis and therapy for infections caused by hiv-1 or hiv-2, cancers, diabetes, asthma, parkinson's disease, ulcers, allergies, congestive heart failure, kidney diseases, sexual disorders |
| 02/05/2002 | US6344339 Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR) |
| 02/05/2002 | US6344323 Preventing cyclooxygenase-2 expression using antisense oligonucleotides that bind polynucleotides encoding cyclooxygenase; therapy for arthritis, ulcers, inflammatory bowel disease, multiple sclerosis, and alzheimer's disease |
| 02/05/2002 | US6344321 Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
| 02/05/2002 | US6344320 Electrophoresis of nascent proteins |
| 02/05/2002 | US6344318 A selex method determining three dimensional structure of nucleic acid ligands by identifying a ligand to a specific target and modifying the nucleotides with a monomer to allow the ligand to mimic the structure and bind the target |
| 02/05/2002 | US6344220 Cayenne, turmeric, ginger, yucca, devil's claw, nettle leaf, black cohosh, alfalfa, celery seeds, glucosamine hydrochloride and mucopolysaccharides; antiartthritic, antiinflamatory agents, analgesics, immunosupressants |
| 02/05/2002 | US6344214 Method for retarding and ameliorating fever blisters and canker sores |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 02/05/2002 | US6344203 Mimicking peptides in cancer therapy |
| 02/05/2002 | US6344198 Polynucleotides used as diagnostic marker for prostate cancer and metastasis |
| 02/05/2002 | US6344197 Methods for treating sepsis |
| 02/05/2002 | US6344196 Compositions and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars |
| 02/05/2002 | US6344192 Ex vivo cultivated t lymphocytes, treated with il-15 or active variants thereof, during the ex vivo cultivation procedure; stimulating formation and promoting survival of memory t cells which recognize a specific antigen in a mammal |
| 02/05/2002 | US6344189 Topical administration of a serine protease inhibitor, such as pai-2. |
| 02/05/2002 | US6344181 Decreased endogenous nitric oxide activation |
| 02/05/2002 | CA2218289C Cd45rb binding compounds for the prevention of transplant rejection |
| 02/05/2002 | CA2150714C Syndecan stimulation of cellular differentiation |
| 02/05/2002 | CA2127284C Protein- and peptide-metal ion pharmaceutical applications |
| 02/05/2002 | CA2110290C Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
| 02/05/2002 | CA2098113C Substances of polypeptide nature useful in human therapy |
| 02/05/2002 | CA2078578C Medical use for tachykinin antagonists |
| 02/05/2002 | CA2072613C Iodothyronine polymers |
| 02/05/2002 | CA2058635C Treatment of thrombotic events |
| 02/05/2002 | CA2057612C Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof |
| 02/05/2002 | CA2051288C Viral targeted destruction of neoplastic cells |
| 02/05/2002 | CA2045290C Plaster with a high content of softening ingredients |
| 02/05/2002 | CA2016521C Fibronectin binding protein as well as its preparation |
| 02/05/2002 | CA2006473C Improved anti-infective therapy |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 02/03/2002 | CA2340783A1 Ampk-related serine/threonine kinase, designated snark |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2313828A1 Post-translational processing of .beta.-secretase (bace): the pro-and transmembrane/cytosolic domains affect its cellular activity and amyloid a.beta. production |
| 01/31/2002 | WO2002008765A2 Basal cell markers in breast cancer and uses thereof |
| 01/31/2002 | WO2002008752A1 Method for the detection of apoptosis by determining apoptosis-specific markers released into an extracellular medium through cellular release mechanisms |
| 01/31/2002 | WO2002008435A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | WO2002008423A2 Adhesion molecules |
| 01/31/2002 | WO2002008422A1 A novel polypeptide, a human myotube protein 10.56 and the polynucleotide encoding the polypeptide |
| 01/31/2002 | WO2002008421A1 A novel polypeptide, a human tumor necrosis factor receptor 21.45 and the polynucleotide encoding the polypeptide |
| 01/31/2002 | WO2002008420A2 A method of down-regulating gene expression |
| 01/31/2002 | WO2002008418A2 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 01/31/2002 | WO2002008402A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same |
| 01/31/2002 | WO2002008401A2 Elongase genes and uses thereof |
| 01/31/2002 | WO2002008399A2 Human kinases |
| 01/31/2002 | WO2002008396A2 Human proteases |
| 01/31/2002 | WO2002008393A2 Serine protease from yersinia enterocolitica |
| 01/31/2002 | WO2002008392A2 Regulation of human matriptase-like serine protease |
| 01/31/2002 | WO2002008389A2 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 01/31/2002 | WO2002008383A2 Sp110, a polypeptide component of the nuclear body |
| 01/31/2002 | WO2002008293A2 Multivalent target binding protein |
| 01/31/2002 | WO2002008292A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 01/31/2002 | WO2002008287A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | WO2002008283A2 Lp120 polypeptides and therapeutic uses thereof |
| 01/31/2002 | WO2002008282A2 Bstp-ras/rerg protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008278A2 Compositions and methods relating to lung specific genes |
| 01/31/2002 | WO2002008276A1 Human prothrombin kringle with endothelial cell growth inhibitory activity, vector and host thereof |
| 01/31/2002 | WO2002008275A2 Genes expressed in obese rat hypothalamus |
| 01/31/2002 | WO2002008273A2 47508, a novel human histone deacetylase family member and uses thereof |
| 01/31/2002 | WO2002008272A2 High affinity soluble interleukin-18 receptor |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008268A2 Leucine-based motif and clostridial neurotoxins |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008262A2 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008261A2 Bstp-trans protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008260A2 Bstp-ecg1 protein and related reagents and methods of use thereof |
| 01/31/2002 | WO2002008258A2 65494, a human g-protein-coupled receptor family member and uses thereof |
| 01/31/2002 | WO2002008257A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof |
| 01/31/2002 | WO2002008256A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008254A1 Compositions and methods for cancer screening |
| 01/31/2002 | WO2002008251A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008250A2 Ghrelin antagonists |
| 01/31/2002 | WO2002008244A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008213A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/31/2002 | WO2002008198A2 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008187A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002007777A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS |
| 01/31/2002 | WO2002007776A1 The protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp10pk) has anti-apoptopic activity |
| 01/31/2002 | WO2002007775A2 Fusion protein for inhibition of lipoprotein secretion |
| 01/31/2002 | WO2002007774A2 Methods for therapy of neurodegenerative disease of the brain |
| 01/31/2002 | WO2002007773A2 Multi-component biological transport systems |
| 01/31/2002 | WO2002007762A1 Human tumor necrosis factor receptors tr21 and tr22 |